Skip to main content
. 2018 May 29;18:104. doi: 10.1186/s12872-018-0850-0

Fig. 3.

Fig. 3

Plasma FFA levels (a) and NT-proBNP levels (b) in patients with NYHA class I/II and NYHA class III/IV. *P<0.05, **P<0.01